Spasmolytic Effect of Flopropione Does Not Involve Catechol-<i>O</i>- methyltransferase (COMT) Inhibition-Reference-Cited by-同舟云学术

Spasmolytic Effect of Flopropione Does Not Involve Catechol-<i>O</i>- methyltransferase (COMT) Inhibition

Published:2024-03-20 Issue:3 Volume:47 Page:660-668
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biological & Pharmaceutical Bulletin

Author:

Amagase Yoko¹²,Hoshiyama Mari¹,Hasegawa Shiho¹,Kanbara Miwa¹,Mizukawa Yumiko¹,Urushidani Tetsuro¹

Affiliation:

1. Department of Pathophysiology, Faculty of Pharmaceutical Sciences, Doshisha Women’s College of Liberal Arts

2. Faculty of Pharmacy, Osaka Medical and Pharmaceutical University

Publisher

Pharmaceutical Society of Japan

Link

https://www.jstage.jst.go.jp/article/bpb/47/3/47_b23-00808/_pdf

Reference36 articles.

1. 1) Package insert of Cospanon Tablets. https://www.info.pmda.go.jp/go/pack/1249007F1032_1_09/.

2. 2) Interview form of Cospanon. http://qws-data.qlife.jp/meds/interview/1249007F1032.

3. 3) Hollingsworth JM, Canales BK, Rogers MAM, Sukumar S, Yan P, Kuntz GM, Dahm P. Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis. BMJ, 355, i6112 (2016).

4. 4) Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 14th Ed. (Brunton LL, Knollmann BC eds.) Chapter 10: Neurotransmission:, Chapter 13: Neuromuscular junction and autonomic ganglia; nicotine, muscle relaxants, and spasmolytics: Hibbs RE, Zambon AC. Chapter 54: Gastrointestinal motility and water flux, emesis, and biliary and pancreatic disease: Sharkey KA, MacNaughton WK (2023).

5. 5) Katzung BG, Vanderah TW. Basic & Clinical Pharmacology 15th Ed., Chapter 9: Biaggioni I. Adrenoceptor agonists & sympathetic drugs: Chapter 28: Aminoff MJ. Pharmacologic management of Parkinsonism & other movement disorders, McGraw-Hill, NY (2021).